1-(4-(2,4-Difluorobenzoyl)piperidin-1-yl)-2,2,2-trifluoroethanone

Catalog No. :
ACHKPM758
CAS No. :
1198287-09-0
Molecular Formula :
C14H12F5NO2
Molecular Weight :
321.24

IUPAC Name:1-(4-(2,4-difluorobenzoyl)piperidin-1-yl)-2,2,2-trifluoroethan-1-one

1-(4-(2,4-Difluorobenzoyl)piperidin-1-yl)-2,2,2-trifluoroethanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$335.00Login to see priceInquiryInquiry
1g95%$840.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-(2,4-Difluorobenzoyl)piperidin-1-yl)-2,2,2-trifluoroethanone
IUPAC Name1-(4-(2,4-difluorobenzoyl)piperidin-1-yl)-2,2,2-trifluoroethan-1-one
MDL No.MFCD12912617
Molecular FormulaC14H12F5NO2
Molecular Weight321.24
SMILESFC(F)(F)C(N1CCC(C(C2=CC=C(F)C=C2F)=O)CC1)=O
InChI KeyLXHBFJXPZNAZHS-UHFFFAOYSA-N
Synonym1-(4-(2,4-Difluorobenzoyl)piperidin-1-yl)-2,2,2-trifluoro-ethanone;Ethanone, 1-[4-(2,4-difluorobenzoyl)-1-piperidinyl]-2,2,2-trifluoro-;1-[4-(2,4-Difluorobenzoyl)-1-piperidinyl]-2,2,2-trifluoroethanone
CAS No.1198287-09-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACHKPM758 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYXHC162 route compound structure diagram
    ACYXHC162106266-04-0 In Stock
  4. Then
  5. ACHKPM758 route product structure diagram
    ACHKPM7581198287-09-0
Inquiry

2. ACHKPM758 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHKPM758 route product structure diagram
    ACHKPM7581198287-09-0
Inquiry

Comments (0)